Jove
Visualize
Contact Us

Related Experiment Videos

Apoptotic and effector pathways in autoimmunity.

A V Chervonsky1

  • 1Jackson Laboratory, Bar Harbor, ME 04609, USA. avc@jax.org

Current Opinion in Immunology
|January 13, 2000
PubMed
Summary

Programmed cell death normally prevents autoimmunity and limits immune damage. However, in autoimmune diseases, this same process can worsen tissue destruction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IFN-gamma affects homing of diabetogenic T cells.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

T-cell receptors: is the repertoire inherently MHC-specific?

Current biology : CB·1997
Same author

The role of Fas in autoimmune diabetes.

Cell·1997
Same author

Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV.

Immunity·1995
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Cell Biology
  • Autoimmunity

Background:

  • Programmed cell death is a critical physiological process for maintaining immune homeostasis.
  • It eliminates autoreactive lymphocytes, preventing autoimmune diseases.
  • It also limits tissue damage from infections and immune responses.

Purpose of the Study:

  • To elucidate the dual role of programmed cell death in immune regulation and autoimmune pathology.
  • To understand how programmed cell death contributes to tissue destruction in autoimmune conditions.

Main Methods:

  • The study reviews existing literature on programmed cell death mechanisms.
  • It analyzes the role of effector mechanisms in normal immune responses versus autoimmune diseases.

Main Results:

  • Programmed cell death is essential for deleting self-reactive immune cells.
  • In autoimmune diseases, programmed cell death pathways become dysregulated.
  • This dysregulation leads to excessive tissue damage mediated by immune cells.

Conclusions:

  • While programmed cell death is protective, its aberrant activation exacerbates autoimmune diseases.
  • Targeting programmed cell death pathways may offer therapeutic strategies for autoimmune conditions.

Related Experiment Videos